Abstract
Over the past two decades there has been intense study of compounds from vertebrates, microorganisms, plants, mushrooms, marine sponges, worms, etc. as well as insects in terms of their antiviral activity. Insects produce a variety of biologically active peptides. One of them is alloferon. The in vitro and in vivo experiments demonstrate that synthetic alloferon has an immunomodulatory properties. It was reported that alloferon and its analogues (alloferon I and II) have antimicrobial properties, as well. The aim of this study was to evaluate in vitro the effect of alloferon I and II, either alone or in combination with human lymphocytes, on human herpesvirus type 1 (HHV-1) McIntyre strain replication. On the base of results we can conclude that alloferon I and II inhibit the replication of HHV-1 McIntyre strain in HEp-2 cells. Enhanced antiviral activity was observed when infected cells were treated with alloferons and unstimulated or phytohemagglutinin PHA-stimulated lymphocytes simultaneously. After application of alloferons and PHA-stimulated lymphocytes to the HHV-1 infected HEp-2 culture, the mean HHV-1 titer reduction for alloferon and II, when used at the highest dose—400 µg/mL, were 3.69 and 3.27 log10/TCID50/mL, respectively.
Similar content being viewed by others
References
Askeland EJ, Newton MR, O’Donnell MA, Lu Y (2012) Bladder cancer immunotherapy: BCG and beyond. Adv Urol. doi:10.1155/2012/181987
Berthold N, Hoffmann R (2014) Cellular uptake of apidaecin 1b and related analogs in gram-negative bacteria reveals novel antibacterial mechanism for proline-rich antimicrobial peptides. Protein Pept Lett 21(4):391–398
Brown TJ, McCrary M, Tyring SK (2002) Antiviral agents: nonantiviral drugs. J Am Acad Dermatol 47:581–599
Chernysh S, Kim SI, Bekker G, Pleskach VA, Filatova NA, Anikin VB, Platonov VG, Bulet P (2002) Antiviral and antitumor peptides from insects. Proc Natl Acad Sci USA 99(20):12628–12632
Cymerys J, Dzieciatkowski T, Golke A, Słońska A, Majewska A, Krzyżowska M, Bańbura MW (2013) Primary cultures of murine neurons for studying herpes simplex virus 1 infection and its inhibition by antivirals. Acta Virol 57(3):339–345
De Clercq E (2011) Outlook of the antiviral drug era, now more than 50 years after description of the first antiviral drug, in antiviral drug strategies, ed E. De Clercq. Wiley, Germany
De Clercq E (2013) Selective anti-herpesvirus agents. Antivir Chem Chemother 23(3):93–101
De Clerq E (2012) Milestones in the discovery of antiviral agents: nucleosides and nucleotides. APSB 2(6):535–548
Fattorini L, Gennaro R, Zanetti M, Tan D, Brunori L, Giannoni F, Pardini M, Orefici G (2004) In vitro activity of protegrin-1 and beta-defensin-1, alone and in combination with isoniazid, against Mycobacterium tuberculosis. Peptides 25(7):1075–1077
Hamelryck TW, Dao-Thi MH, Poortmans F, Chrispeels MJ, Wyns L, Loris R (1996) The crystallographic structure of phytohemagglutinin-L. J Biol Chem 271(34):20479–20485
Kim H, Im JP, Kim JS, Kang JS, Lee WJ (2015) Alloferon alleviates dextran sulfate sodium-induced colitis. Immune Netw 15(3):135–141
Kitazato K, Wang Y, Kobayashi N (2007) Viral infectious disease and natural products with antiviral activity. Drug Discov Ther 1(1):14–22
Krawczyk E, Luczak M, Kniotek M, Majewska A, Kawecki D, Nowaczyk M (2005) Immunomodulatory activity and influence on mitotic divisions of N-benzoylphenylisoserinates of Lactarius sesquiterpenoid alcohols in vitro. Planta Med 71(9):819–824
Krawczyk E, Kniotek M, Nowaczyk M, Dzieciatkowski T, Przybylski M, Majewska A, Luczak M (2006) N-acetylphenylisoserinates of Lactarius sesquiterpenoid alcohols-cytotoxic, antiviral, antiproliferative and immunotropic activities in vitro. Planta Med 72(7):615–620
Kuczer M, Dziubasik K, Midak-Siewirska A, Zahorska R, Łuczak M, Konopińska D (2010) Studies of insect peptides alloferon, any-GS and their analogues. Synthesis and antiherpes activity. J Pept Sci 16(4):186–189
Kuczer M, Czarniewska E, Rosiński G (2013a) Novel biological effects of alloferon and its selected analogues: structure–activity study. Regul Pept 183:17–22
Kuczer M, Majewska A, Zahorska R (2013b) New alloferon analogues: synthesis and antiviral properties. Chem Biol Drug Des 81(2):302–309
Lasek W, Janyst M, Wolny R, Zapała Ł, Bocian K, Drela N (2015) Immunomodulatory effects of inosine pranobex on cytokine production by human lymphocytes. Acta Pharm 65:171–180
Lee N, Bae S, Kim H, Kong JM, Kim HR, Cho BJ, Kim SJ, Seok SH, Hwang YI, Kim S, Kang JS, Lee WJ (2011) Inhibition of lytic reactivation of Kaposi’s sarcoma-associated herpesvirus by alloferon. Antivir Ther 16(1):17–26
Lei X, Limin Y, Wenjun L (2013) Distinct evolution process among type I interferon in mammals. Protein Cell 4(5):383–392
Majewska A, Lasek W, Janyst M, Mlynarczyk G (2015a) Inhibition of adenovirus multiplication by inosine pranobex and interferon-α in vitro. CEJI (in press)
Majewska A, Mlynarczyk-Bonikowska B, Malejczyk M, Mlynarczyk G, Majewski S (2015b) Antiviral medication in sexually transmitted diseases. Part II: HIV. Mini Rev Med Chem 15(2):93–103
Majewska A, Lasek W, Janyst M, Mlynarczyk G (2016) In vitro inhibition of HHV-1 replication by inosine pranobex and interferon- α. Acta Pol Pharm Drug Res (in press)
Miyanoshita A, Hara S, Sugiyama M, Asaoka A, Taniai K, Yukuhiro F, Yamakawa M (1996) Isolation and characterization of a new member of the insect defensin family from a beetle Allomyrina dichotoma. Biochem Biophys Res Commun 220(3):526–531
Mlynarczyk-Bonikowska B, Majewska A, Malejczyk M, Mlynarczyk G, Majewski S (2013) Antiviral medication in sexually transmitted diseases. Part I: HSV, HPV. Mini Rev Med Chem 13(13):1837–1845
Mosa C, Trizzino A, Di Marco F, D’Angelo P, Farruggia P (2014) Treatment of human papillomavirus infection with interferon alpha and ribavirin in a patient with acquired aplastic anemia. Int Inf Dis 23:25–27
Orhan IE (2014) Pharmacognosy: science of natural products in drug discovery. Bioimpacts 4(3):109–110
Pranczyk J, Jacewicz D, Wyrzykowski D, Chmurzynski L (2015) Platinum(II) and palladium(II) complex compounds as anti-cancer drugs. Methods of cytotoxicity determination. Curr Pharm Anal 10:2–9
Reed LJ, Muench HA (1938) A simple method of estimating fifty per cent endpoint. Am J Hyg 27:493–497
Ryu MJ, Anikin V, Hong SH, Jeon H, Yu YG, Yu MH, Chernysh S, Lee C (2008) Activation of NF-kappa B by alloferon through down-regulation of antioxidant proteins and I-kappa-B-alpha. Mol Cell Biochem 313:91–102
Sagar S, Kaur M, Minneman KP (2010) Antiviral lead compounds from marine sponges. Mar Drugs 8(10):2619–2638
Sherman RA, Hall MJ, Thomas S (2000) Medicinal maggots: an ancient remedy for some contemporary afflictions. Annu Rev Entomol 45:55–81
Slocinska M, Marciniak P, Rosinski G (2008) Insects antiviral and anticancer peptides: new leads for the future? Protein Pept Lett 15(6):578–585
Strasfeld L, Chou S (2010) Antiviral drug resistance: mechanisms and clinical implications. Infect Dis Clin North Am 24(2):413–437
Upadhyay RK (2010) Animal proteins and peptides: anticancer and antimicrobial potential. J Pharm Res 3(12):3100–3108
Acknowledgment
This study was funded by The Medical University of Warsaw.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
Anna Majewska, Witold Lasek, Mariola Kuczer, Grażyna Młynarczyk confirm that this article content has no conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain studies with human or animal subjects performed by any of the authors that should be approved by Ethics Committee.
Rights and permissions
About this article
Cite this article
Majewska, A., Lasek, W., Kuczer, M. et al. Inhibitory Effect of Alloferons in Combination with Human Lymphocytes on Human Herpesvirus 1 (HHV-1) Replication In Vitro. Int J Pept Res Ther 22, 255–261 (2016). https://doi.org/10.1007/s10989-015-9506-4
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10989-015-9506-4